Xuqiu Lei
Senior Scientist, Discovery Immunology Merck
Seminars
Wednesday 4th November 2026
Panel Discussion: Targeting Novel Pathways Beyond IL & JAK Inhibitors to Differentiate Therapies & Expand Treatment Options
8:30 am
- Exploring novel biological pathways beyond established mechanisms, unlocking new therapeutic angles, to differentiate pipelines in a crowded market
- Validating emerging targets with translational data, reducing scientific uncertainty, to increase success rates in development
- Expanding modality and pathway diversity, broadening treatment options, to address unmet patient needs
